Backup With Combivir or Single Dose (SD) Truvada in Order to Avoid Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance After SD Nevirapine for the Prevention of Mother-to-child Transmission (PMTCT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00346567
Recruitment Status : Completed
First Posted : June 30, 2006
Last Update Posted : February 23, 2016
University of Copenhagen
Information provided by:
Rigshospitalet, Denmark

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2010
  Study Completion Date : April 2011